← Leaderboards
Gaurav Sahay
Oregon State University
$8,129,419
Attributed
$8,958,731
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,958,731 · 5
By mechanism
R01$8,096,035 · 3
R15$441,324 · 1
R21$421,372 · 1
Top collaborators
- Conroy Ghin Chee Sun3 shared
Others in their field
Other Emerging Leaders on “Messenger Rna”
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Norbert Pardi · University Of Pennsylvania$13,084,354
- Neil King · University Of Washington$12,677,393
- Kirsten Frieda · Spatial Genomics, Inc.$12,006,066
- Wilton B Williams · Duke University$11,389,307
- Julie Ake · National Institute Of Allergy And Infectious Diseases$10,950,000
Research focus
Messenger RnaCellsGene DeliveryLipid NanoparticleGene TherapyTransfectionBiologicalMediatingSurfaceProtein ExpressionIn VivoUptakeIn VitroNanoparticleGenesMouse ModelProteinsStructureToxic EffectPropertyEndosomesMutationEngineeringLibraries
Grant awards (16)
Developing gene editing platforms for retinal degeneration.$617,949
R01 · FY2025 · EY · contact PI
Delivering inhalable nanoparticles containing AI-optimized CFTR mRNA with a novel microfluidic device for treatment of CF$599,652
R01 · FY2025 · HL · contact PI
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines$558,135
R01 · FY2025 · CA
Developing gene editing platforms for retinal degeneration.$625,649
R01 · FY2024 · EY · contact PI
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines$530,230
R01 · FY2024 · CA
Nanoparticles based mRNA delivery for treatment of cystic fibrosis$658,627
R01 · FY2023 · HL · contact PI
Developing gene editing platforms for retinal degeneration.$627,134
R01 · FY2023 · EY · contact PI
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines$570,260
R01 · FY2023 · CA
Nanoparticles based mRNA delivery for treatment of cystic fibrosis$658,627
R01 · FY2022 · HL · contact PI
Developing gene editing platforms for retinal degeneration.$648,444
R01 · FY2022 · EY · contact PI
Nanoparticles based mRNA delivery for treatment of cystic fibrosis$658,627
R01 · FY2021 · HL · contact PI
Overcoming gene delivery barriers to the back of the eye$183,227
R21 · FY2021 · EY · contact PI
Nanoparticles based mRNA delivery for treatment of cystic fibrosis$666,748
R01 · FY2020 · HL · contact PI
Overcoming gene delivery barriers to the back of the eye$238,145
R21 · FY2020 · EY · contact PI
Nanoparticles based mRNA delivery for treatment of cystic fibrosis$675,953
R01 · FY2019 · HL · contact PI
Mechanisms of Intracellular trafficking and endosomal escape of nanoparticles for mRNA delivery$441,324
R15 · FY2017 · EB · contact PI